Stay updated on Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.

Latest updates to the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the government funding lapse notice and the prior v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a general site-wide notice about government funding and NIH operating status, and a new page revision tag (v3.4.1), replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedUI updates add a glossary toggle, color-coded change highlights, and a new Revision: v3.4.0 label on the history page.SummaryDifference1%

- Check35 days agoChange DetectedThe Record History, Study Record Versions, and related versioning/identity elements are removed, eliminating the ability to view or compare past versions of the study record.SummaryDifference8%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added and v3.3.3 was removed in the Record History, which is a minor administrative update to the version history and does not affect study details or status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the Record History, and the footer now removes the HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.